[Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children]
Related Experiment Videos
Objectives:
In young children with meningitis, blood or cerebrospinal fluid (CSF) analysis cannot differentiate all cases of viral meningitis (VM) from bacterial meningitis (BM). Empirical antibiotic therapy is often given. As new markers are needed, we compared serum proCalcitonin (PCT) with CSF analysis for C-reactive protein (CRP) and interleukin-6 (IL6).
Patients And Methods:
PCT was measured with a chemoluminescent assay in the sera of 23 children (aged 3 months to 14 years) hospitalized for BM and in 51 patients with VM.
Results:
Initial CRP (mean 143.3 mg/l, range 28-351 and mean 13.9, range 1-48), CSF proteins (mean 2.2, range 0.4-4.74 and mean 0.57, range 0.12-2.72) and white blood cell count in CSF (range 240-17500 and 20-3200) in BM and VM respectively, were not sufficiently discriminative to distinguish between BM and VM. Twenty-four of the 51 patients with VM were given antibiotics. IL6 values at admission showed an overlap zone (> 100 pg/ml in 7/19 patients with VM and < 100 pg/ml in 1/8 patients with BM. PCT was discriminative in all cases: mean PCT in BM was 61 micrograms/l (range 4.8-335) and 0.33 in VM (range 0-1.7; p < 0.001). No production of PCT was detected in CSF. After antibiotic therapy, PCT decreased and reached undetectable levels after recovery.
Conclusion:
PCT is a sensitive and specific marker for early diagnosis of viral meningitis versus bacterial meningitis in children.
Insights
Serum procalcitonin (PCT) effectively distinguishes bacterial meningitis from viral meningitis in children. This new marker aids early diagnosis, unlike traditional CSF analysis, improving treatment decisions for pediatric meningitis.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Diagnostics
- Biomarker Research
Background:
- Meningitis in children often requires empirical antibiotic treatment due to diagnostic challenges.
- Current cerebrospinal fluid (CSF) and blood markers like C-reactive protein (CRP) and interleukin-6 (IL-6) show limited ability to differentiate viral meningitis (VM) from bacterial meningitis (BM).
Purpose of the Study:
- To evaluate serum procalcitonin (PCT) as a diagnostic marker for differentiating VM from BM in pediatric patients.
- To compare the efficacy of PCT with established markers such as CRP and IL-6.
Main Methods:
- Serum PCT levels were measured using a chemiluminescent assay in 23 children with BM and 51 children with VM.
- CSF analysis, including protein levels and white blood cell counts, was performed.
- IL-6 levels were also assessed for comparison.
Main Results:
- Traditional markers (CRP, CSF protein, WBC count) were insufficient to reliably distinguish BM from VM.
- Interleukin-6 (IL-6) showed an overlap in values between VM and BM groups.
- Serum PCT levels were highly discriminative, with significantly higher levels in BM (mean 61 µg/l) compared to VM (mean 0.33 µg/l; p < 0.001).
- PCT was undetectable in CSF, and levels decreased with antibiotic treatment in BM patients.
Conclusions:
- Serum procalcitonin (PCT) is a sensitive and specific biomarker for the early and accurate diagnosis of bacterial meningitis versus viral meningitis in children.
- PCT offers a reliable method to guide antibiotic therapy decisions in pediatric meningitis cases.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Pneumonia III: Complications and Assessment
Encephalitis l: Introduction